Life sciences

  • Up to £10,000 now available for collaborative cancer care innovation projects

    Life Sciences Hub Wales and the Academy of Medical Sciences have launched their Cancer Care Accelerator Fund. Up to £10,000 in seed funding alongside bespoke support is now available for UK-based organisations working on collaborative cancer innovation projects. Improving cancer outcomes is an urgent priority in the UK. Better treatment, earlier diagnosis, and improved patient [...]

  • £1.45m grant funds new drugs to fight deadly candida infections

    The Medical Research Council has awarded £1.45m to develop new efflux-resistant antifungal drugs for Candida auris and other Candida species, pathogens with mortality rates over 50 per cent. The grant will support research into invasive candidiasis, tackling rising drug resistance in fungi the World Health Organization (WHO) has classified as “critical”. Professor Miraz Rahman at [...]

  • Blood test could streamline early Alzheimer’s detection, study finds

    Researchers have linked self-reported memory decline to blood biomarkers, raising the prospect of simpler Alzheimer’s diagnosis for underserved groups. The study of 5,712 Hispanic and Latino adults aged 50–86 found connections between certain blood proteins and perceived problems with memory and thinking, suggesting a less invasive alternative to current methods. Scientists at the University of [...]

  • Double C-loop lens proves rock-solid stability in landmark review

    Centre for Sight today announced the publication of a major international review paper co-authored by its Medical Director, Mr Sheraz Daya, highlighting the stability of a unique Double C-Loop intraocular lens (IOL) design. The peer-reviewed study — which analysed 19 clinical trials involving 1,428 eyes — concludes that the POD Double C-Loop platform provides exceptional [...]

  • Researchers to build first medical AI model with globally representative data

    A research consortium of over 100 study groups in more than 65 countries has launched a collaborative effort to develop the first globally representative AI foundation model in medicine, using 100 million eye images.  The Global RETFound initiative is one of the largest medical AI collaborations ever undertaken, producing one of the most geographically and [...]

  • Eden Ben appointed CEO as Amorphical progresses regulatory pathway

    Amorphical, developer of nano-amorphous mineral-based pharmacologic agents for health conditions, has announced the appointment of Eden Ben as its Chief Executive Officer. Ben will guide the company forward as it accelerates its regulatory pathway strategy in the U.S. and Europe, and advances its pipeline of disease-modifying therapeutics. With a background in biomedical engineering and management, [...]

  • NHS to fast-track patients with head and neck cancer into vaccine trial

    Patients with advanced head and neck cancers in England will be fast-tracked into a trial of a new cancer vaccine. The investigational cancer vaccine uses mRNA technology to help the immune system recognise and kill cancer cells containing human papillomavirus proteins. More than 100 patients with advanced head and neck cancer in England will be [...]

  • How breakthrough could boost next generation of mental health drugs

    A new study has revealed how a key serotonin receptor works, offering clues for developing faster, more targeted treatments for mental health conditions. Researchers at the Icahn School of Medicine at Mount Sinai reported new findings on the 5-HT1A receptor – a key drug target for antidepressants and psychedelics – that help explain its molecular [...]

  • Briya launches first clinical-grade AI for medical and epidemiological research

    Briya has announced the launch of Briya AIRE, the world’s first clinical-grade AI research assistant built to accelerate biomedical and clinical decision making. Designed to “think” in the language of medicine, clinical research and epidemiology, AIRE turns months of manual data analysis into actionable insights in minutes – enabling faster, cost-effective discovery across biopharma and [...]

  • Leeds healthtech firm secures £6m investment

    Leeds-based paediatric healthtech company Little Journey has raised £6m to expand its digital tools supporting children through medical care. The Series A investment will support the commercial growth and product development of the company’s cloud-based platform, which helps children and caregivers prepare for medical procedures and clinical trials. Little Journey’s mobile app uses interactive digital [...]